Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MYCL pseudogene 1 (MYCLP1) is a processed pseudogene of the MYCL (L-myc) gene, a member of the myc oncogene family. Unlike the functional MYCL1 gene which encodes a transcription factor implicated in cancer, MYCLP1 does not encode a functional protein due to its pseudogenic nature (e.g., frameshifts, premature stop codons). Therefore, MYCLP1 itself does not serve as a receptor, enzyme, transporter, or classical drug target. No therapies or biomarker roles have been associated with it, and there is no evidence for a direct biological function or disease association. It is not considered a therapeutic target and is not actionable in the context of drug discovery or molecular targeting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MYCL pseudogene 1 (MYCLP1).